Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Calcitonin inhibits both osteoclast formation and bone resorption, and is a primary treatment for patients with hypercalcemia and increased bone turnover. However, the clinical utility of calcitonin is limited because patients become refractory to calcitonin after several days (the calcitonin "escape phenomenon"). The molecular basis for calcitonin "escape" is unclear. To determine the regulatory mechanisms controlling calcitonin receptor (CTR) expression in osteoclasts and their precursors, we treated immature mononuclear precursors for human osteoclast-like multinucleated cells (MNC) formed in vitro with 1,25-(OH)2D3, to induce their differentiation to committed mononuclear precursors, and mature multinucleated osteoclasts, and used reverse transcriptase (RT)-PCR to assess expression of CTR mRNA in both committed mononuclear precursors and MNC. The PCR fragment produced was cloned and sequenced to confirm that it was derived from CTR mRNA. CTR mRNA expression was detected in mononuclear MNC precursors after 7 d of 1,25-(OH)2D3 treatment. It was also present in osteoclast-like MNC and highly purified giant cells from osteoclastomas, but not in monocytes or macrophage polykaryons formed in vitro. Calcitonin markedly decreased CTR but not actin mRNA expression in giant cells and MNC after 12 h, and removal of calcitonin restored CTR mRNA expression. Similarly, calcitonin decreased calcitonin-induced adenylate cyclase activity. These data suggest: (a) downregulation of CTR gene expression by calcitonin may in part explain the calcitonin "escape phenomenon"; and (b) expression of CTR mRNA occurs in mononuclear osteoclast precursors within 7 d after exposure to 1,25-(OH)2D3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The desensitization of the cells to calcitonin was found to be the result of a ligand-induced internalization of the CTR, as well as inhibition of de novo synthesis of the receptor, and has been confirmed in both human and murine osteoclast cultures (194,212).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [194]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
A highly sensitive adenylate cyclase assay
Salomon, Y., Londos, C., & Rodbell, M. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90222-x · Cited by 4,169
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Nicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454
CHAMBERS, T. J., McSHEEHY, P. M. J., THOMSON, B. M., & FULLER, K. (1985) · Endocrinology · doi:10.1210/endo-116-1-234 · Cited by 422
Ng, S.-Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., & Kedes, L. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2720-2732.1985 · Cited by 372
Davies, J., Warwick, J., Totty, N., Philp, R., Helfrich, M., & Horton, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.4.1817 · Cited by 365
KURIHARA, N., CHENU, C., MILLER, M., CIVIN, C., & ROODMAN, G. D. (1990) · Endocrinology · doi:10.1210/endo-126-5-2733 · Cited by 227
Self-citationGorn, A. H., Lin, H. Y., Yamin, M., Auron, P. E., Flannery, M. R., Tapp, D. R., Manning, C. A., Lodish, H. F., Krane, S. M., & Goldring, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116046 · Cited by 211
Self-citationNg, S. Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., & Kedes, L. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2720 · Cited by 209
Effect of Calcitonin and Glucocorticoids in Combination on the Hypercalcemia of Malignancy
BINSTOCK, M. L., & MUNDY, G. R. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-269 · Cited by 199
TAKAHASHI, N., AKATSU, T., SASAKI, T., NICHOLSON, G. C., MOSELEY, J. M., JOHN MARTIN, T., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-123-3-1504 · Cited by 168
Comparative study of available medical therapy for hypercalcemia of malignancy
Mundy, G. R., Wilkinson, R., & Heath, D. A. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90961-0 · Cited by 163
MACDONALD, B. R., TAKAHASHI, N., MCMANUS, L. M., HOLAHAN, MUNDY, G. R., & ROODMAN, G. D. (1987) · Endocrinology · doi:10.1210/endo-120-6-2326 · Cited by 162
Self-citationOhsaki, Y. (1992) · Endocrinology · doi:10.1210/en.131.5.2229 · Cited by 161
Self-citationHATTERSLEY, G., & CHAMBERS, T. J. (1989) · Endocrinology · doi:10.1210/endo-125-3-1606 · Cited by 152
Calcitonin Binding Sites in Bone: Relationships to Biological Response and “Escape”
Tashjian, A. H., WRIGHT, D. R., Ivey, J. L., & Pont, A. (1978) · Elsevier eBooks · doi:10.1016/b978-0-12-571134-0.50012-0 · Cited by 130
Salmon calcitonin therapy for paget's disease of bone the problem of acquired clinical resistance
Singer, F. R., Fredericks, R. S., & Minkin, C. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780231012 · Cited by 119
Calcitonin Receptors on Cultured Human Lymphocytes
Marx, S. J., Aurbach, G. D., Gavin, J. R., & Buell, D. W. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42130-3 · Cited by 116
Lord, D. K., Cross, N. C. P., Bevilacqua, M. A., Rider, S. H., Gorman, P. A., GROVES, A. V., Moss, D., Sheer, D., & Cox, T. M. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15488.x · Cited by 96
Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
Findlay, D. M., DeLuise, M., Michelangeli, V. P., Ellison, M. L., & Martin, T. J. (1980) · PubMed · Cited by 96
Responses of Fetal Rat Bone to Thyrocalcitonin in Tissue Culture
FRIEDMAN, J., Au, W. Y. W., & Raisz, L. G. (1968) · Endocrinology · doi:10.1210/endo-82-1-149 · Cited by 85
Calcitonin Receptors of Human Osteoclastoma
Nicholson, G. C., Horton, M. A., Sexton, P. M., D’Santos, C. S., Moseley, J. M., Kemp, B. E., Pringle, J. A. S., & Martin, T. (1987) · Hormone and Metabolic Research · doi:10.1055/s-2007-1011887 · Cited by 77
Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures.
Takahashi, N., Kukita, T., MacDonald, B. R., Bird, A., Mundy, G. R., McManus, L. M., Miller, M., Boyde, A., Jones, S. J., & Roodman, G. D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113916 · Cited by 76
Self-citationBone resorption by isolated human osteoclasts in vitro: Effects of calcitonin
Murrills, R. J., Shane, E. J., Lindsay, R., & Dempster, D. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040219 · Cited by 70
Gutierrez, G. E., Mundy, G. R., Derynck, R., Hewlett, E. L., & Katz, M. S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47665-x · Cited by 61
Self-citationKURIHARA, N., GLUCK, S., & ROODMAN, G. D. (1990) · Endocrinology · doi:10.1210/endo-127-6-3215 · Cited by 60
Self-citationTranscriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron
Alcantara, O., Reddy, S. V., Roodman, G. D., & Boldt, D. H. (1994) · Biochemical Journal · doi:10.1042/bj2980421 · Cited by 55
Self-citationKukita, T., McManus, L. M., Miller, M., Civin, C. I., & Roodman, G. D. (1989) · PubMed · Cited by 53
Self-citationCalcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D)
Findlay, D. M., Michelangeli, V. P., Moseley, J. M., & Martin, T. J. (1981) · Biochemical Journal · doi:10.1042/bj1960513 · Cited by 52
Lin, M.-C., Rajfer, J., Swerdloff, R. S., & González-Cadavid, N. F. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90002-e · Cited by 44
Bouizar, Z., Rostène, W. H., & MILHAUD, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5125 · Cited by 43
Berthois, Y., Dong, X.-F., Roux-Dossetto, M., & Martin, P. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90201-i · Cited by 42
Treatment of hypercalcemia associated with malignancy.
Mazzaferri, E. L., O’Dorisio, T. M., & LoBuglio, A. F. (1978) · PubMed · Cited by 33
Relationship between Internalization and Calcitonin Induced Receptor Loss in T 47D Cells*
Findlay, D. M., & Martin, T. J. (1984) · Endocrinology · doi:10.1210/endo-115-1-78 · Cited by 32
Treatment of hypercalcaemia associated with malignancy.
Wilkinson, R. (1984) · BMJ · doi:10.1136/bmj.288.6420.812 · Cited by 27
Kanehisa, J. (1989) · Bone · doi:10.1016/8756-3282(89)90010-0 · Cited by 27
INDEPENDENT DOWN-REGULATION OF INSULIN AND CALCITONIN RECEPTORS ON A HUMAN TUMOUR CELL LINE
Findlay, D. M., Luise, M. D., Michelangeli, V. P., & Martin, T. J. (1981) · Journal of Endocrinology · doi:10.1677/joe.0.0880271 · Cited by 26
Krieger, N. S., Feldman, R. S., & Tashjian, A. H. (1982) · Calcified Tissue International · doi:10.1007/bf02411233 · Cited by 26
Liggett, S. B. (1991) · Pharmacological Research · doi:10.1016/1043-6618(91)90119-i · Cited by 26
The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat
Glajchen, N., Thomas, S., Jowell, P. S., Epstein, S., Ismail, F., & Fallon, M. D. (1990) · Calcified Tissue International · doi:10.1007/bf02555821 · Cited by 21
Multinucleated rat alveolar macrophages express functional receptors for calcitonin
Vignery, A., Raymond, M., Qian, H. Y., Wang, F., & Rosenzweig, S. A. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.6.f1026 · Cited by 21
Lerner, U. H., Ransjö, M., Klaushofer, K., Hörandner, H., Hoffmann, O., Czerwenka, E., Koller, K., & Peterlik, M. (1989) · Bone · doi:10.1016/8756-3282(89)90134-8 · Cited by 16
Calcitonin effects on osteoclastic resorption: the ‘escape phenomenon’ revisited
Heersche, J. N. M. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90895-k · Cited by 13
Research works printed but not linked: 2
- [3]3. Bouizar, Z., W. H. Rostene, and G. Milhaud. 1987. Downregulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography. Proc. Natl. Acad. Sci. USA. 84:5125–5128. J.
- [43]43. Lin, M. C., J. Rajfer, R. S. Swerdloff, and N. F. Gonzalez-Cadavid. 1993. Testosterone down-regulates the levels of androgen receptor mRNA in smooth mu 'us at a ti csa avu aia a oa s eusn Steroid Biochem. Mol. Biol. 45(5):333–343.
Cited by
Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122
Becker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Cell biology of the osteoclast
Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 571
“Calcitonin downregulates expression of CTR in osteoclast precursors and mature osteoclasts in part by inhibiting CTR mRNA expression [88].”
BackgroundSelf-citationZara, J. N., Siu, R. K., Zhang, X., Shen, J., Ngo, R., Lee, M., Li, W., Chiang, M., Chung, J., Kwak, J., et al. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0555 · Cited by 560
Gravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., & Goldring, S. R. (1998) · Europe PMC (PubMed Central) · Cited by 516
Self-citation
Metadata
- Authors
- Takahashi, S., Goldring, S., Katz, M., Hilsenbeck, S., Williams, R., & Roodman, G. D.
- Affiliations
- United States Department of Veterans Affairs (US)
- Harvard University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-01-01
- Volume
- 95
- Issue
- 1
- Pages
- 167-171
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295397
- OpenAlex
- W1975884885
- Cited by
- 125
- References
- 44
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 2 · 2016: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01am035188-01)
- National Cancer Institute (P30CA 54174)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 39539, AR41336, R01AR041336)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- calcitonin receptor, calcitonin, osteoclastogenesis, osteoclast-like multinucleated cells, osteoclast precursors, receptor down-regulation, 1,25-dihydroxyvitamin D3, adenylate cyclase, bone resorption, hypercalcemia
- MeSH terms
- Base Sequence, Bone Marrow, Bone Marrow Cells, Calcitonin, Calcitriol, Cell Differentiation, Cells, Cultured, Humans, Macrophages, Molecular Sequence Data, Monocytes, Osteoclasts, RNA, Messenger, Stem Cells, Down-Regulation, Polymerase Chain Reaction, Receptors, Calcitonin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.